IMM 1.45% 34.0¢ immutep limited

research report out, page-30

  1. 701 Posts.
    From the report:
    "PRR currently has about 10 patient enquiries regarding treatment via the DHCC."

    So, @ ~70k(?) per treatment = 700,000 on the books.


    Can't find any mention in the timeline of interim phase 2b results.
  2. This thread is closed.

    You may not reply to this discussion at this time.

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.